Copy Number Variations of Human Ribosomal Genes in Health and Disease: Role and Causes
Frontiers in Bioscience-Landmark · 2025
DOI: 10.31083/fbl25765 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Natalia N Veiko und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Biology, Research Centre of Medical Genetics, 115478 Moscow, Russia. Hauptthemen laut MEDLINE: DNA Copy Number Variations, DNA, Ribosomal, Schizophrenia, Cystic Fibrosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Background
A number of association studies have linked ribosomal DNA gene copy number (rDNA CN) to aging and pathology. Data from these studies are contradictory and depend on the quantitative method.
Methods
The hybridization technique was used for rDNA quantification in human cells. We determined the rDNA CN from healthy controls (HCs) and patients with schizophrenia (SZ) or cystic fibrosis (CF) (total number of subjects N = 1124). For the first time, rDNA CN was quantified in 105 long livers (90–101 years old). In addition, we conducted a joint analysis of the data obtained in this work and previously published by our group (total, N = 3264).
Results
We found increased rDNA CN in the SZ group (534 ± 108, N = 1489) and CF group (567 ± 100, N = 322) and reduced rDNA CN in patients with mild cognitive impairment (330 ± 60, N = 93) compared with the HC group (422 ± 104, N = 1360). For the SZ, CF, and HC groups, there was a decreased range of rDNA CN variation in older age subgroups compared to child subgroups. For 311 patients with SZ or CF, rDNA CN was determined two or three times, with an interval of months to several years. Only 1.2% of patients demonstrated a decrease in rDNA CN over time. We did not find significant rDNA CN variation in eight different organs of the same patient or in cells of the same fibroblast population.
Conclusions
The results suggest that rDNA CN is a relatively stable quantitative genetic trait statistically associated with some diseases, which however, can change in rare cases under conditions of chronic oxidative stress. We believe that age- and disease-related differences between the groups in mean rDNA CN and its variance are caused by the biased elimination of carriers of marginal (predominantly low) rDNA CN values.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Biology, Research Centre of Medical Genetics, 115478 Moscow, Russia.
- Department of Public Health, National Research Institute of Public Health n.a. N.А. Semashko, 105064 Moscow, Russia.
- Research Department, N. A. Alexeev Clinical Psychiatric Hospital №1, 115447 Moscow, Russia.
Förderung
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Veiko, N. N., Ershova, E. S., Kondratyeva, E. I., Porokhovnik, L. N., Zinchenko, R. A., Melyanovskaya, Y. L., Krasovskiy, S. A., Vasilyeva, T. P., Kostyuk, G. P., Zakharova, N. V., & Kostyuk, S. V. (2025). Copy Number Variations of Human Ribosomal Genes in Health and Disease: Role and Causes. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl25765
Vancouver
Veiko NN, Ershova ES, Kondratyeva EI, Porokhovnik LN, Zinchenko RA, Melyanovskaya YL, et al. Copy Number Variations of Human Ribosomal Genes in Health and Disease: Role and Causes. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl25765
BibTeX
@article{Veiko2025,
author = {Veiko, Natalia N and Ershova, Elizaveta S and Kondratyeva, Elena I and Porokhovnik, Lev N and Zinchenko, Rena A and Melyanovskaya, Yuliya L and Krasovskiy, Stanislav A and Vasilyeva, Tatiana P and Kostyuk, George P and Zakharova, Natalia V and Kostyuk, Svetlana V},
title = {Copy Number Variations of Human Ribosomal Genes in Health and Disease: Role and Causes},
journal = {Frontiers in Bioscience-Landmark},
year = {2025},
doi = {10.31083/fbl25765}
}
EUVIMED